ConductScience.org, home

Paper9706063

Single-dose pharmacokinetics of rifapentine in elderly men.

Keung AC and 2 others. Pharm Res, 1998. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Single-dose pharmacokinetics of rifapentine in elderly men. Papers, record 9706063. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9706063

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-dose pharmacokinetics of rifapentine in elderly men.
PubMed
Journal
Pharm Res
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2026-10-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Keung ACA C
2Eller MGM G
3Weir SJS J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
RifampinMajor topic
Aged
Aged, 80 and over
Half-Life
Humans
Male
Reference Values

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12155555Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.Am Rev Respir Dis1990https://conductscience.org/library/papers/2155555PubMed
26262396Gastric emptying rate in the elderly: implications for drug therapy.J Am Geriatr Soc1981https://conductscience.org/library/papers/6262396PubMed
35459997Adult lean body mass declines with age: some longitudinal observations.Metabolism1970https://conductscience.org/library/papers/5459997PubMed
44627605Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years.J Gerontol1972https://conductscience.org/library/papers/4627605PubMed
5728306Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings].Br J Clin Pharmacol1978https://conductscience.org/library/papers/728306PubMed
66845400Pharmacokinetic studies of rifampicin in the elderly.Ther Drug Monit1983https://conductscience.org/library/papers/6845400PubMed
77791396Symposium on geriatrics--Part I: Drug prescribing for elderly patients.Mayo Clin Proc1995https://conductscience.org/library/papers/7791396PubMed
89698286Disposition and metabolism of 14C-rifapentine in healthy volunteers.Drug Metab Dispos1998https://conductscience.org/library/papers/9698286PubMed
92834842In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.Tubercle1987https://conductscience.org/library/papers/2834842PubMed
104893850The aging gastrointestinal tract.Am J Surg1969https://conductscience.org/library/papers/4893850PubMed
116356275Rifampin: mechanisms of action and resistance.Rev Infect Dis1983https://conductscience.org/library/papers/6356275PubMed
128590563Epidemiology of tuberculosis in Europe.Eur Respir J Suppl1995https://conductscience.org/library/papers/8590563PubMed
132686883Clinical pharmacokinetic considerations in the elderly. An update.Clin Pharmacokinet1989https://conductscience.org/library/papers/2686883PubMed
141956210The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.Methods Find Exp Clin Pharmacol1991https://conductscience.org/library/papers/1956210PubMed
158335033Identification of populations at risk in drug testing and therapy: application to elderly patients.Eur J Drug Metab Pharmacokinet1993https://conductscience.org/library/papers/8335033PubMed
16639902The effect of ageing on the biliary excretion of ouabain in the rat.Exp Gerontol1978https://conductscience.org/library/papers/639902PubMed
178785251The clinical pharmacokinetics of rifabutin.Clin Infect Dis1996https://conductscience.org/library/papers/8785251PubMed
182688002Tuberculosis in the elderly.Semin Respir Infect1989https://conductscience.org/library/papers/2688002PubMed
198064768Pharmacokinetics of drugs in the elderly.J R Soc Med1994https://conductscience.org/library/papers/8064768PubMed
202663734Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 1.Int J Clin Pharmacol Ther Toxicol1989https://conductscience.org/library/papers/2663734PubMed

See all 23 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
39898756Comparative study on the bioavailability and bioequivalence of rifapentine capsules in humans.Front Pharmacol2024https://conductscience.org/library/papers/39898756PubMed
31591118A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31591118PubMed
29066867Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough?Drug Des Devel Ther2017https://conductscience.org/library/papers/29066867PubMed
28242663Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28242663PubMed
27270284Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27270284PubMed
19075046New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19075046PubMed
16251279Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16251279PubMed
10935428Treatment of tuberculous infection and disease in children: the North American perspective.Paediatr Drugs1999https://conductscience.org/library/papers/10935428PubMed
10722501Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10722501PubMed
9806107Rifapentine.Drugs1998https://conductscience.org/library/papers/9806107PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9706063

GET https://conductscience.org/api/papers/v1/9706063/references?page=2